🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of acetaminophen, asserting the companies withheld potential risks that the pain reliever created to pediatric brain development.

This legal action comes a month after Former President Trump promoted an unproven link between using acetaminophen - alternatively called acetaminophen - while pregnant and autism spectrum disorder in young ones.

The attorney general is taking legal action against J&J, which previously sold the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a official comment, he said they "betrayed America by gaining financially from pain and promoting medication without regard for the potential hazards."

The company says there is insufficient reliable data linking acetaminophen to autism.

"These companies deceived for years, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the well-being of American women and children."

On its online platform, the company also said it had "regularly reviewed the relevant science and there is insufficient valid information that shows a established connection between using acetaminophen and autism spectrum disorder."

Associations acting on behalf of doctors and health professionals concur.

ACOG has declared acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and fever, which can pose serious health risks if not addressed.

"In more than two decades of investigation on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of pregnancy results in neurodevelopmental disorders in offspring," the group stated.

This legal action references recent announcements from the previous government in claiming the drug is potentially dangerous.

Recently, Trump generated worry from public health officials when he instructed expectant mothers to "fight like hell" not to take Tylenol when unwell.

Federal regulators then published an announcement that physicians should contemplate reducing the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in children has not been established.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in spring to initiate "comprehensive study program" that would determine the origin of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a single cause of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and impairment that influences how persons encounter and relate to the surroundings, and is recognized using doctors' observations.

In his legal document, the attorney general - who supports Trump who is campaigning for US Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the corporations "remove any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit mirrors the grievances of a assembly of parents of children with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in 2022.

The court rejected the lawsuit, declaring research from the parents' expert witnesses was lacking definitive proof.